+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003



Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003



Mmwr. Morbidity and Mortality Weekly Report 52(41): 986-987



Severe acute respiratory syndrome (SARS) was identified in 2003 as an infectious disease caused by the SARS-associated coronavirus (SARS-CoV), a member of the coronavirus family not observed previously in humans. Because its sequence data differ from that of known human coronaviruses, SARS-CoV is suspected to have crossed the species barrier between an animal host and humans. The SARS outbreak began in China's Guangdong Province, where approximately 1,500 probable cases were identified during November 2002-June 2003. Detection of SARS-like coronavirus has been reported previously in masked palm civets (sometimes called civet cats) and a raccoon dog for sale in a live animal market in Shenzhen municipality. This report summarizes results of an investigation conducted by public health authorities in Guangdong Province, which compared the seroprevalence of SARS-CoV IgG antibody in animal traders (i.e., workers in live animal markets) with that of persons in control groups. The results indicated that 13% of the animal traders, none of whom had SARS diagnosed, had IgG antibody to SARS-CoV, compared with 1%-3% of persons in three control groups. Although the results provide indirect support for the hypothesis of an animal origin for SARS, they also underscore the need for detailed patient histories and more focused animal studies to confirm an animal origin for SARS.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050001088

Download citation: RISBibTeXText

PMID: 14561956


Related references

The prevalence of SARS in Guangdong province from 2003 to 2004 and its control. Chinese Journal of Zoonoses 22(4): 326-329, 2006

Anti-SARS virus antibody responses against human SARS-associated coronavirus and animal SARS-associated coronavirus-like virus. Chinese Medical Journal 117(11): 1723-1725, 2004

Analysis of risk factors of SARS coronavirus infection among population in contact with wild animals in Guangdong Province. China Tropical Medicine 6(7): 1125-1126, 1156, 2006

Dynamic observation to SARS-CoV antibody and antigen in late 2003 in Guangdong. Zhonghua Weishengwuxue He Mianyixue Zazhi 25(2): 107-110, 2005

Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet (North American Edition) 362(9393): 1353-1358, 2003

Sero-epidemiological characteristics of antibody to SARS-associated coronavirus in Gansu Province. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 18(4): 325-327, 2004

Animal reservoirs for SARS-like coronavirus in southern China. Hong Kong Medical Journal 17(Suppl. 6): 36-40, 2011

Laboratory diagnosis of four recent sporadic cases of community-acquired SARS, Guangdong Province, China. Emerging Infectious Diseases 10(10): 1774-1781, 2004

Seroprevalence of antibody to severe acute respiratory syndrome (SARS)-associated coronavirus among health care workers in SARS and non-SARS medical wards. Clinical Infectious Diseases 38(12): E116-E118, 2004

Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. Journal of Clinical Microbiology 43(7): 3054-3058, 2005

Analysis of schistosomiasis surveillance between 1996 and 2003 in Sihui City, Guangdong Province, China. Journal of Tropical Medicine Guangzhou 5(1): 100-101, 2005

SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. Vaccine 23(42): 4959-4968, 2005

Prevalence of blindness and moderate and severe visual impairment among adults aged 50 years or above in Yangxi County of Guangdong Province: the China Nine-Province Survey. Chinese Journal of Ophthalmology 50(3): 167-172, 2015

An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. Journal of Pathology 206(3): 251-259, 2005

Detection of the anti-SARS-coronavirus specific antibody levels in 156 SARS patients. Zhongguo Shi Yan Xue Ye Xue Za Zhi 11(5): 441-443, 2003